| RS2141014161 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141014662 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141014847 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016007 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016108 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016305 |
SPRED1
|
Health Risk |
Likely pathogenic |
Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome |
| RS2141016437 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016462 |
SPRED1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome and Noonan-related syndrome, Legius syndrome |
| RS2141016500 |
SPRED1
|
Health Risk |
Likely pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016553 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016685 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016692 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016711 |
SPRED1
|
Health Risk |
Likely pathogenic |
Noonan syndrome and Noonan-related syndrome, Noonan syndrome and Noonan-related syndrome |
| RS2141016737 |
SPRED1
|
Health Risk |
Pathogenic |
Legius syndrome, Legius syndrome |
| RS2141016934 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141019036 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141019983 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141022949 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141022986 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141023054 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141023331 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141023340 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141023345 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141023403 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141024241 |
PMM2
|
Health Risk |
Likely pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141024987 |
SPPL2A
|
Health Risk |
Pathogenic |
Immunodeficiency 86, Immunodeficiency 86 |
| RS2141025675 |
KIAA0586
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS2141027825 |
SPG11
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 11 |
| RS2141027919 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141027980 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141029118 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141033061 |
TTC8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2141033426 |
TTC8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2141034312 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141034530 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141037423 |
TELO2
|
Health Risk |
Likely pathogenic |
— |
| RS2141038703 |
TTC8
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2141041750 |
ZMYM2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities |
| RS2141041805 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141041961 |
ZMYM2
|
Health Risk |
Likely pathogenic |
— |
| RS2141042140 |
ZMYM2
|
Health Risk |
Pathogenic |
Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities, Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities |
| RS2141044380 |
TTC8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2141051168 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141051210 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141051275 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141051516 |
PMM2
|
Health Risk |
Pathogenic |
PMM2-congenital disorder of glycosylation, PMM2-congenital disorder of glycosylation |
| RS2141056788 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141056921 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141061879 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141062122 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141064916 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter disease type 1, Bartter disease type 1 |
| RS2141076409 |
RASGRP1
|
Health Risk |
Pathogenic |
— |
| RS2141079375 |
CYP19A1
|
Health Risk |
Pathogenic |
Aromatase deficiency, Aromatase deficiency |
| RS2141084327 |
MYO5A
|
Health Risk |
Likely pathogenic |
Griscelli syndrome type 1, Griscelli syndrome type 1 |
| RS2141088947 |
IFT140
|
Health Risk |
Conflicting classifications of pathogenicity |
See cases, Saldino-Mainzer syndrome |
| RS2141098146 |
TRPM1
|
Health Risk |
Likely pathogenic |
Congenital stationary night blindness 1C, Congenital stationary night blindness 1C |
| RS2141098660 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141102601 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141102654 |
CAPN3
|
Health Risk |
Pathogenic |
— |
| RS2141102673 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy |
| RS2141102811 |
CAPN3
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS2141105806 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2141105930 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141106328 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141106403 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141106935 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141106983 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141107140 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141107413 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141108180 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141115303 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2141115536 |
RASGRP1
|
Health Risk |
Pathogenic |
— |
| RS2141121011 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141121140 |
MYO5A
|
Health Risk |
Pathogenic |
Griscelli syndrome type 1, Griscelli syndrome type 1 |
| RS2141121333 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141123410 |
CYP19A1
|
Health Risk |
Pathogenic |
— |
| RS2141124327 |
SOCS1
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome with immunodeficiency, Autoinflammatory syndrome with immunodeficiency |
| RS2141124542 |
SOCS1
|
Health Risk |
Pathogenic |
Autoinflammatory syndrome with immunodeficiency, Autoinflammatory syndrome with immunodeficiency |
| RS2141124790 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141125120 |
SOCS1
|
Health Risk |
Likely pathogenic |
Autoinflammatory syndrome with immunodeficiency, Autoinflammatory syndrome with immunodeficiency |
| RS2141125364 |
SOCS1
|
Health Risk |
Likely pathogenic |
— |
| RS2141126974 |
GRIN2A
|
Health Risk |
Likely pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141129448 |
THSD4
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 12 |
| RS2141130040 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141130246 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS2141130589 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS2141132961 |
GLIS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 7, Nephronophthisis 7 |
| RS2141133179 |
LRRK1
|
Health Risk |
Pathogenic |
— |
| RS2141133924 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Inborn genetic diseases |
| RS2141135900 |
CLN6
|
Health Risk |
Likely pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS2141135967 |
CLN6
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2141136011 |
CLN6
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2141136108 |
CLN6
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis, Ceroid lipofuscinosis |
| RS2141136701 |
GRIN2A
|
Health Risk |
Pathogenic |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS2141137200 |
CLN6
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141137336 |
CLN6
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis, Neuronal ceroid lipofuscinosis |
| RS2141137371 |
GJA3
|
Health Risk |
Likely pathogenic |
— |
| RS2141138001 |
GJA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cataract 14 multiple types, Cataract 14 multiple types |
| RS2141138155 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2141138365 |
GJA3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cataract 14 multiple types, Cataract 14 multiple types |